Thus, we propose that TREM-1 may serve as a biomarker for tumor progression and a useful target for reprogramming the immunosuppressive tumor microenvironment of the host and that TREM2 might play an important role in balancing the inflammatory signals within the tumor. The gene discussed is TREM1; the disease is neoplasm.